ABOUT ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)

Supplemental studies in progress counsel that ARV-825 may additionally be effective in improving the reaction to estrogen deprivation (aromatase inhibition), another component of ordinary of care in ER+ breast cancer.- "Our study exposed the vital part on the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLC